<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2026 (6) TMI 620 - TELANGANA HIGH COURT</title>
    <link>https://www.taxtmi.com/caselaws?id=793239</link>
    <description>The writ petition challenging a GST adjudication order and consequential recovery proceedings was not entertained because the statutory remedy remained available and the challenge was brought after more than two years. Relying on Glaxo Smith Kline Consumer Health Care Ltd., the HC held that such delay weighed against invocation of writ jurisdiction and dismissed the petition, while leaving the petitioner free to approach the statutory authority if permissible in law.</description>
    <language>en-us</language>
    <pubDate>Mon, 23 Mar 2026 00:00:00 +0530</pubDate>
    <lastBuildDate>Thu, 11 Jun 2026 08:33:02 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=906424" rel="self" type="application/rss+xml"/>
    <item>
      <title>2026 (6) TMI 620 - TELANGANA HIGH COURT</title>
      <link>https://www.taxtmi.com/caselaws?id=793239</link>
      <description>The writ petition challenging a GST adjudication order and consequential recovery proceedings was not entertained because the statutory remedy remained available and the challenge was brought after more than two years. Relying on Glaxo Smith Kline Consumer Health Care Ltd., the HC held that such delay weighed against invocation of writ jurisdiction and dismissed the petition, while leaving the petitioner free to approach the statutory authority if permissible in law.</description>
      <category>Case-Laws</category>
      <law>GST</law>
      <pubDate>Mon, 23 Mar 2026 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=793239</guid>
    </item>
  </channel>
</rss>